TruePath - CTO Case 3: Superficial Femoral Artery, 250 mm

SFA

  • 82-year-old male, CABG, claudication
  • Left 250 mm eccentric lesion with severe calcification


Crossing the Proximal Cap

  • 18 seconds of activation time
  • Calcium outline aids in confirming true lumen


TruePath™ Device Successfully Crossing Lesion

  • TruePath Device crossed total occlusion
  • Angioplasty and stenting performed


Final Result

Lesion successfully crossed, good flow restored

Boston Scientific currently has no FDA-approved stent for use in the SFA. Images provided by Dierk Scheinert, MD. Results from case studies are not predictive of results in other cases. Results in other cases may vary.

Top